Since the first FDA biosimilar approval of filgrastim-sndz (Zarxio) in 2015, a total of 44 biosimilars for 15 originator products have been approved and more than 20 are marketed.
Rising seniors population to further impact N B healthcare country94.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from country94.ca Daily Mail and Mail on Sunday newspapers.
Public Consultation Open for Strategic Refocus of EMDG Program miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ According to a new survey from Protiviti and NC State University, uncertainty in today s marketplace is presenting both new and ongoing risks.